Sign in

CIK 0001826457 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Monte Rosa Therapeutics, Inc.

Sign in to watch
Ticker
GLUE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-949-2643
Business address
321 HARRISON AVENUE, SUITE 900, BOSTON, MA, 02118
Former names
Monte Rosa Therapeutics, Inc.
  1. 3 Insider Initial Statement of Ownership
  2. CERT Other Certification
  3. 8-A12B Other Registration of Securities
  4. CORRESP Other Correspondence Between Filers and SEC Staff
  5. CORRESP Other Correspondence Between Filers and SEC Staff
  6. CORRESP Other Correspondence Between Filers and SEC Staff
  7. S-1/A Offering Registration Statement
  8. UPLOAD Other SEC-generated Letter
  9. CORRESP Other Correspondence Between Filers and SEC Staff
  10. CORRESP Other Correspondence Between Filers and SEC Staff
  11. S-1/A Offering Registration Statement
  12. UPLOAD Other SEC-generated Letter
  13. S-1 Offering Registration Statement
  14. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  15. DRSLTR Other Correspondence Related to Draft Registration Statement
  16. DRS/A Other Draft Registration Statement
  17. UPLOAD Other SEC-generated Letter
  18. DRS/A Other Draft Registration Statement
  19. DRS Other Draft Registration Statement
  20. D Other Notice of Sales of Unregistered Securities

Page 20 of 21 · 401 filings